Merck

Cardio-metabolic disorders

Cardio-metabolic disorders

We have a long history of making an impact in cardio-metabolic disorders, such as type 2 diabetes and cardiovascular disease.

More than 60 years ago, we introduced our first cardiovascular therapy – and our scientific efforts to deeply understand cardio-metabolic disorders have continued

Cardio-metabolic disorders include cardiovascular diseases and metabolic diseases, such as type 2 diabetes. These represent some of the most serious health challenges of the 21st century.

Advancements in cardio-metabolic research can make an impactful difference for patients, and there is still much more work to be done. We strive for scientific excellence and innovation in all stages of research, from discovery through approval and afterwards.